[HTML][HTML] Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies

RK Sahu, S Ruhi, AK Jeppu, HA Al-Goshae… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
The pathetic malignant mesothelioma (MM) is a extremely uncommon and confrontational
tumor that evolves in the mesothelium layer of the pleural cavities (inner lining-visceral …

[HTML][HTML] Systemic inflammation and lung cancer: is it a real paradigm? Prognostic value of inflammatory indexes in patients with resected non-small-cell lung cancer

A Mazzella, E Maiolino, P Maisonneuve, M Loi… - Cancers, 2023 - mdpi.com
Simple Summary Systemic inflammation and changes in the inflammatory status are
frequent features of lung cancer. There is a close interconnection between cancer …

[HTML][HTML] Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies

RK Sahu, S Ruhi, AK Jeppu, HA Al-Goshae… - Frontiers in …, 2023 - frontiersin.org
The pathetic malignant mesothelioma (MM) is a extremely uncommon and confrontational
tumor that evolves in the mesothelium layer of the pleural cavities (inner lining-visceral …

Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan

S Hasegawa, Y Shintani, T Takuwa, K Aoe… - Cancer …, 2024 - Wiley Online Library
Due to the scarcity of large‐sized prospective databases, the Japanese Joint Committee for
Lung Cancer Registry conducted a nationwide prospective registry for newly diagnosed and …

[HTML][HTML] ARDS after Pneumonectomy: How to Prevent It? Development of a Nomogram to Predict the Risk of ARDS after Pneumonectomy for Lung Cancer

A Mazzella, S Mohamed, P Maisonneuve, A Borri… - Cancers, 2022 - mdpi.com
Simple Summary In the modern era, characterized by parenchymal-sparing procedures, in
some cases pneumonectomy remains the only therapeutic approach to achieving …

[HTML][HTML] A Novel Two-Gene Expression-Based Prognostic Score in Malignant Pleural Mesothelioma

V Shivarov, G Blazhev, A Yordanov - Diagnostics, 2023 - mdpi.com
Background: Malignant pleural mesothelioma (MPM) is a rare cancer type with an
increasing incidence worldwide. We aimed to develop a rational gene expression-based …

Relationship Between Preoperative Inflammation Ratios Derived From Preoperative Blood Cell Count and Postoperative Pulmonary Complications in Patients …

A de Fréminville, M Saad, E Sage, C Pricopi… - … of Cardiothoracic and …, 2024 - Elsevier
Objective Evaluation of the association of inflammatory cell ratios, especially neutrophil-to-
lymphocyte ratio (NLR), based on preoperative complete blood counts, with postoperative …

[HTML][HTML] Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma

M Willems, A Scherpereel, E Wasielewski… - Frontiers in …, 2023 - frontiersin.org
Background Only a fraction of patients with malignant pleural mesothelioma (MPM) will
respond to chemo-or immunotherapy. For the majority, the condition will irremediably …

[HTML][HTML] Malignant pleural mesothelioma mimics thoracic empyema: A case report

YH Yao, YS Kuo - World Journal of Clinical Cases, 2023 - ncbi.nlm.nih.gov
BACKGROUND Thoracic empyema and malignant pleural mesothelioma (MPM) are distinct
medical conditions with similar symptoms, including cough, chest pain, and breathing …

[PDF][PDF] WJCC

QY Yao, ML Fu, Q Zhao, XM Zheng, K Tang… - World, 2023 - pdfs.semanticscholar.org
The prevention, early discovery and effective treatment of patients with hepatocellular
carcinoma (HCC) remain a global medical challenge. At present, HCC is still mainly treated …